Ivacaftor-Induced Changes in Plasma Chemokines Suggest Inflammatory Pathways Altered by CFTR Restoration Differ From Pathways Involved in CF Pulmonary Exacerbations. This evidence concerns the gene CFTR and cystic fibrosis.